Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organon & Co

9.13
+0.41004.70%
Pre-market: 9.160.0300+0.33%09:19 EDT
Volume:19.11M
Turnover:164.53M
Market Cap:2.37B
PE:3.17
High:9.27
Open:8.61
Low:8.05
Close:8.72
Loading ...

Organon Expects 2025 Sales Of $6.125B-$6.325B Versus Consensus Of $6.471B

Benzinga
·
13 Feb

Organon & Co - Q4 2024 Net Income of $109 Million, $0.42 per Diluted Share

THOMSON REUTERS
·
13 Feb

Organon & Co - 2025 Revenue Guidance Range of $6.125 Billion - $6.325 Billion

THOMSON REUTERS
·
13 Feb

Organon & Co Q4 Total Revenue $1.592 Bln

THOMSON REUTERS
·
13 Feb

Organon & Co FY2025 Shr View $4.10, REV View $6.47 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
13 Feb

Organon Q4 2024 Adj EPS $0.90 Beats $0.87 Estimate, Sales $1.59B Inline

Benzinga
·
13 Feb

Organon (OGN) Q4 Earnings Report Preview: What To Look For

StockStory
·
12 Feb

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Organon (OGN) and Inventiva (IVA)

TIPRANKS
·
12 Feb

Organon & Co : JP Morgan Cuts Target Price to $18 From $20

THOMSON REUTERS
·
27 Jan

With 79% ownership, Organon & Co. (NYSE:OGN) boasts of strong institutional backing

Simply Wall St.
·
24 Jan

Organon transferred with a Hold at TD Cowen

TIPRANKS
·
15 Jan

FDA approves Organon’s VTAMA cream, 1% for the treatment for AD

TipRanks
·
17 Dec 2024

Organon Says Vtama Cream Approved by FDA for Atopic Dermatitis

MT Newswires Live
·
16 Dec 2024

BRIEF-FDA Approves Vtama® Cream, 1% For The Treatment Of Atopic Dermatitis

Reuters
·
16 Dec 2024

FDA Approves Vtama® (Tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

THOMSON REUTERS
·
16 Dec 2024

BRIEF-FDA Approves Dermavant Science's Vtama For Topical Treatment Of Atopic Dermatitis In Adult & Pediatric Patients 2 Years & Older

Reuters
·
14 Dec 2024

FDA: Approves Dermavant Science's Vtama for Topical Treatment of Atopic Dermatitis in Adult & Pediatric Patients 2 Years & Older - Website

THOMSON REUTERS
·
14 Dec 2024

Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price

Simply Wall St.
·
13 Dec 2024

Merck-marketed asthma drug linked to psychiatric issues: report

seekingalpha
·
22 Nov 2024

Organon's (NYSE:OGN) Earnings Are Weaker Than They Seem

Simply Wall St.
·
08 Nov 2024